Trupanion (NASDAQ:TRUP) Upgraded at Piper Sandler

Trupanion (NASDAQ:TRUP) was upgraded by equities research analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued to investors on Thursday, MarketBeat.com reports. The firm currently has a $57.00 price target on the financial services provider’s stock. Piper Sandler’s price target suggests a potential upside of 22.53% from the company’s current price.

Other equities research analysts have also recently issued research reports about the stock. Stifel Nicolaus increased their price target on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Northland Securities increased their price target on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $45.33.

Trupanion Price Performance

TRUP stock opened at $46.52 on Thursday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. Trupanion has a 52 week low of $19.69 and a 52 week high of $57.90. The firm’s fifty day moving average is $50.80 and its 200 day moving average is $45.95. The firm has a market cap of $1.97 billion, a P/E ratio of -145.38, a P/E/G ratio of 8.27 and a beta of 1.61.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. The company had revenue of $327.50 million for the quarter, compared to analyst estimates of $321.79 million. During the same quarter last year, the firm earned ($0.10) EPS. The firm’s quarterly revenue was up 14.6% compared to the same quarter last year. Research analysts predict that Trupanion will post -0.2 earnings per share for the current year.

Insider Transactions at Trupanion

In related news, Director Murray B. Low sold 2,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the transaction, the director now directly owns 131,513 shares in the company, valued at $6,926,789.71. This trade represents a 1.50 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 9,867 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. In the last ninety days, insiders sold 28,597 shares of company stock valued at $1,522,082. Company insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Dimensional Fund Advisors LP increased its stake in Trupanion by 24.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 137,833 shares of the financial services provider’s stock valued at $4,052,000 after purchasing an additional 26,941 shares in the last quarter. Renaissance Technologies LLC bought a new stake in Trupanion during the 2nd quarter valued at about $4,739,000. Intech Investment Management LLC bought a new stake in Trupanion during the 2nd quarter valued at about $291,000. Public Sector Pension Investment Board increased its stake in Trupanion by 7.3% during the 2nd quarter. Public Sector Pension Investment Board now owns 79,555 shares of the financial services provider’s stock valued at $2,339,000 after purchasing an additional 5,405 shares in the last quarter. Finally, Marshall Wace LLP increased its stake in Trupanion by 11.9% during the 2nd quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock valued at $32,181,000 after purchasing an additional 116,496 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.